|
|
|
Insider
Information: |
Eastham Karin |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
9 |
|
Direct
Shares |
195,379 |
|
Indirect Shares
|
1,000 |
|
|
Direct
Value |
$2,209,351 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
196,379 |
|
|
Total
Value |
$2,209,351 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Diversa Corp |
VRNM |
Sr. VP Finance, CFO & ... |
2004-04-29 |
6,419 |
2004-04-29 |
1,000 |
Premium* |
|
Sgx Pharmaceuticals, Inc. |
SGXP |
Director |
2008-08-20 |
0 |
|
0 |
Premium* |
|
Illumina Inc |
ILMN |
Director |
2019-05-23 |
10,049 |
2008-05-16 |
0 |
Premium* |
|
Geron Corporation |
GERN |
Director |
2023-01-13 |
109,047 |
2009-05-29 |
0 |
Premium* |
|
Trius Therapeutics Inc |
TSRX |
Director |
2013-09-11 |
0 |
2013-09-11 |
0 |
Premium* |
|
Amylin Pharmaceuticals Inc |
AMLN |
Director |
2012-08-08 |
0 |
2011-05-24 |
0 |
Premium* |
|
Veracyte, Inc. |
VCYT |
Director |
2024-04-01 |
33,125 |
2021-11-01 |
0 |
Premium* |
|
Nektar Therapeutics |
NKTR |
Director |
2022-09-16 |
23,233 |
2018-09-27 |
0 |
Premium* |
|
Personalis, Inc. |
PSNL |
Director |
2022-05-17 |
13,506 |
2021-05-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
122 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NKTR |
Nektar Therapeutics |
Director |
|
2020-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
9,100 |
24,100 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2017-08-02 |
4 |
OE |
$75.66 |
$817,128 |
D/D |
10,800 |
24,388 |
0 |
- |
|
VRNM |
Diversa Corp |
Sr. VP Finance, CFO, & Sec |
|
2004-01-12 |
4 |
AS |
$10.50 |
$115,520 |
D/D |
(11,000) |
25,419 |
|
- |
|
GERN |
Geron Corporation |
Director |
|
2013-07-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(45,000) |
26,500 |
0 |
- |
|
GERN |
Geron Corporation |
Director |
|
2013-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,824 |
30,324 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Director |
|
2023-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
9,674 |
33,125 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Director |
|
2024-04-01 |
4 |
AS |
$21.65 |
$216,528 |
D/D |
(10,000) |
33,125 |
0 |
% |
|
VCYT |
Veracyte, Inc. |
Director |
|
2023-02-28 |
4 |
OE |
$12.12 |
$121,200 |
D/D |
10,000 |
33,451 |
0 |
- |
|
GERN |
Geron Corporation |
Director |
|
2014-06-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,500) |
33,470 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
Director |
|
2021-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
10,200 |
34,300 |
0 |
- |
|
GERN |
Geron Corporation |
Director |
|
2014-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,646 |
35,970 |
0 |
- |
|
VRNM |
Diversa Corp |
officerTitle |
|
2003-07-10 |
4 |
AS |
$11.44 |
$115,797 |
I/I |
(10,000) |
37,419 |
|
- |
|
GERN |
Geron Corporation |
Director |
|
2014-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
5,577 |
39,047 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Director |
|
2023-03-16 |
4 |
OE |
$12.12 |
$227,250 |
D/D |
18,750 |
42,201 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Director |
|
2024-04-01 |
4 |
OE |
$13.19 |
$131,900 |
D/D |
10,000 |
43,125 |
0 |
- |
|
VRNM |
Diversa Corp |
Sr. VP Finance, CFO, & Sec |
|
2004-04-26 |
4 |
OE |
$1.73 |
$60,494 |
D/D |
35,000 |
51,419 |
|
- |
|
GERN |
Geron Corporation |
Director |
|
2010-07-09 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
60,000 |
0 |
- |
|
GERN |
Geron Corporation |
Director |
|
2011-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
69,000 |
0 |
- |
|
GERN |
Geron Corporation |
Director |
|
2012-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,500) |
71,500 |
0 |
- |
|
GERN |
Geron Corporation |
Director |
|
2011-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
74,000 |
0 |
- |
|
GERN |
Geron Corporation |
Director |
|
2022-04-20 |
4 |
OE |
$1.41 |
$49,350 |
D/D |
35,000 |
74,047 |
0 |
- |
|
GERN |
Geron Corporation |
Director |
|
2023-01-13 |
4 |
OE |
$1.10 |
$38,500 |
D/D |
35,000 |
109,047 |
0 |
- |
|
122 Records found
|
|
Page 5 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|